Globus Medical (GMED) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Broadcom secures role as key Apple supplier with chip deal through 2031
Globus Medical Reports Second Quarter 2017 Results
August 2, 2017 4:30 PM EDTAUDUBON, Pa., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions manufacturer, today announced its financial results for the second quarter ended June 30, 2017.
Worldwide sales were $152.4 million, an increase of 10.8% as reported, or 11.0% in constant currencySecond quarter net income was $28.7 million, or 18.8% of salesDiluted earnings per share (EPS) were $0.29Non-GAAP diluted EPS were $0.32Non-GAAP adjusted EBITDA was 35.1% of salesDavid Paul, Chairman and CEO said, Our worldwide sales for the second quarter were $152.4 million, an increase of 10.8%... More
